These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 7588486)
1. Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults. Asiedu P; Moulton T; Blum CB; Roldan E; Lolacono NJ; Graziano JH Environ Health Perspect; 1995; 103(7-8):734-9. PubMed ID: 7588486 [TBL] [Abstract][Full Text] [Related]
2. Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning. Bradberry S; Vale A Clin Toxicol (Phila); 2009 Aug; 47(7):617-31. PubMed ID: 19663612 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adults. Dart RC; Hurlbut KM; Maiorino RM; Mayersohn M; Aposhian HV; Hassen LV J Pediatr; 1994 Aug; 125(2):309-16. PubMed ID: 8040783 [TBL] [Abstract][Full Text] [Related]
4. Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men. Torres-Alanís O; Garza-Ocañas L; Piñeyro-López A Hum Exp Toxicol; 2002 Nov; 21(11):573-7. PubMed ID: 12507251 [TBL] [Abstract][Full Text] [Related]
5. The current role of 2,3-dimercaptosuccinic acid (DMSA) in the management of childhood lead poisoning. Glotzer DE Drug Saf; 1993 Aug; 9(2):85-92. PubMed ID: 8397892 [TBL] [Abstract][Full Text] [Related]
6. Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning. Bradberry S; Sheehan T; Vale A QJM; 2009 Oct; 102(10):721-32. PubMed ID: 19700440 [TBL] [Abstract][Full Text] [Related]
7. Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication. Graziano JH; Lolacono NJ; Moulton T; Mitchell ME; Slavkovich V; Zarate C J Pediatr; 1992 Jan; 120(1):133-9. PubMed ID: 1309865 [TBL] [Abstract][Full Text] [Related]
8. Determination and metabolism of dithiol chelating agents. VI. Isolation and identification of the mixed disulfides of meso-2,3-dimercaptosuccinic acid with L-cysteine in human urine. Maiorino RM; Bruce DC; Aposhian HV Toxicol Appl Pharmacol; 1989 Feb; 97(2):338-49. PubMed ID: 2538007 [TBL] [Abstract][Full Text] [Related]
9. Determination and metabolism of dithiol chelating agents. XV. The meso-2,3-dimercaptosuccinic acid-cysteine (1:2) mixed disulfide, a major urinary metabolite of DMSA in the human, increases the urinary excretion of lead in the rat. Maiorino RM; Aposhian MM; Xu ZF; Li Y; Polt RL; Aposhian HV J Pharmacol Exp Ther; 1993 Dec; 267(3):1221-6. PubMed ID: 8263783 [TBL] [Abstract][Full Text] [Related]
10. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation. Maiorino RM; Akins JM; Blaha K; Carter DE; Aposhian HV J Pharmacol Exp Ther; 1990 Aug; 254(2):570-7. PubMed ID: 2166796 [TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects. Aposhian HV; Maiorino RM; Dart RC; Perry DF Clin Pharmacol Ther; 1989 May; 45(5):520-6. PubMed ID: 2541962 [TBL] [Abstract][Full Text] [Related]
12. Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data. Thurtle N; Greig J; Cooney L; Amitai Y; Ariti C; Brown MJ; Kosnett MJ; Moussally K; Sani-Gwarzo N; Akpan H; Shanks L; Dargan PI PLoS Med; 2014 Oct; 11(10):e1001739. PubMed ID: 25291378 [TBL] [Abstract][Full Text] [Related]
13. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning. Bradberry S; Vale A Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620 [TBL] [Abstract][Full Text] [Related]
14. Meso-2,3-dimercaptosuccinic acid in the treatment of occupationally exposed lead workers. Restek-Samarzija N; Blanusa M; Pizent A; Samarzija M; Turk R; Corović N; Jurasović J Arh Hig Rada Toksikol; 1998 Jun; 49(2):137-45. PubMed ID: 9919719 [TBL] [Abstract][Full Text] [Related]
15. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead. van Eijkeren JC; Olie JD; Bradberry SM; Vale JA; de Vries I; Clewell HJ; Meulenbelt J; Hunault CC Clin Toxicol (Phila); 2017 Feb; 55(2):133-141. PubMed ID: 27919185 [TBL] [Abstract][Full Text] [Related]
16. Short-term efficacy of oral dimercaptosuccinic acid in children with low to moderate lead intoxication. Besunder JB; Anderson RL; Super DM Pediatrics; 1995 Oct; 96(4 Pt 1):683-7. PubMed ID: 7567330 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of meso-2,3-dimercaptosuccinic acid (DMSA) in children with elevated blood lead concentrations. Chisolm JJ J Toxicol Clin Toxicol; 2000; 38(4):365-75. PubMed ID: 10930052 [TBL] [Abstract][Full Text] [Related]
18. meso-2,3-Dimercaptosuccinic acid: chemical, pharmacological and toxicological properties of an orally effective metal chelating agent. Aposhian HV; Aposhian MM Annu Rev Pharmacol Toxicol; 1990; 30():279-306. PubMed ID: 2160791 [TBL] [Abstract][Full Text] [Related]
19. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations. Graziano JH; Lolacono NJ; Meyer P J Pediatr; 1988 Oct; 113(4):751-7. PubMed ID: 2845043 [TBL] [Abstract][Full Text] [Related]